Skip to main content

Table 3 Administrative and clinical outcomes by fluid cohort

From: Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

Outcome/Complication Saline (n = 1558) % (n) Balanced (n = 1558) % (n) Unadjusted odds ratio (95 % CI) Adjusted odds ratio (95 % CI)
Administrative Outcomes
Cardiac 8.66 (135) 4.43 (69) 0.488 (0.362–0.659) 0.387 (0.276–0.544)
Hemorrhage 0.71 (11) 0.51 (8) 0.726 (0.291–1.809) 0.681 (0.264–1.757)
Infectious 10.14 (158) 6.03 (94) 0.569 (0.436–0.742) 0.526 (0.396–0.699)
Gastrointestinal 5.46 (85) 5.13 (80) 0.938 (0.685–1.284) 0.881 (0.636–1.220)
Neurologic 1.16 (18) 0.83 (13) 0.72 (0.352–1.474) 0.585 (0.275–1.245)
Acute renal failure 4.36 (68) 3.34 (52) 0.757 (0.524–1.093) 0.676 (0.447–1.023)
Respiratory failure 5.46 (85) 3.47 (54) 0.622 (0.439–0.882) 0.624 (0.429–0.908)
New organ failure 9.11 (142) 7.12 (111) 0.765 (0.59–0.991) 0.707 (0.506–0.986)
Clinical Outcomes
Hospital mortality 3.27 (51) 1.03 (16) 0.307 (0.174–0.54) 0.373 (0.204–0.681)
30–day readmissions 9.5 (148) 7.64 (119) 0.788 (0.612–1.014) 0.801 (0.618–1.036)
60–day readmissions 13.54 (211) 10.91 (170) 0.782 (0.63–0.97) 0.804 (0.645–1.004)
90–day readmissions 16.56 (258) 12.58 (196) 0.725 (0.593–0.886) 0.735 (0.598–0.904)
Cardiac
Dysrhythmia 10.65 (166) 6.87 (107) 0.618 (0.48–0.797) 0.632 (0.485–0.823)
Cardiac stress 6.42 (100) 2.05 (32) 0.306 (0.204–0.458) 0.289 (0.188–0.483)
Heart failure 4.04 (63) 1.48 (23) 0.356 (0.219–0.576) 0.447 (0.268–0.747)
Hemorrhage/Hematologic
Coagulopathya 11.09 (150) 7.71 (106) 0.67 (0.516–0.87) 0.602 (0.450–0.806)
Received blood transfusion 2.92 (46) 2.27 (36) 0.777 (0.5–1.209) 0.629 (0.389–1.018)
Bleeding 20.09 (313) 19.96 (311) 0.992 (0.832–1.182) 1.134 (0.942–1.365)
Infectious     
Pneumonia 6.03 (94) 2.12 (33) 0.337 (0.225–0.504) 0.349 (0.226–0.539)
Sepsis 10.53 (164) 5.65 (88) 0.509 (0.389–0.666) 0.534 (0.401–0.711)
Urinary tract infection 5.91 (92) 4.69 (73) 0.783 (0.571–1.074) 0.884 (0.632–1.237)
Line infection 0.77 (12) 0
Gastrointestinal
Cholecystitis 4.75 (74) 3.53 (55) 0.734 (0.514–1.048) 0.753 (0.517–1.098)
Renal
Acute Kidney Injury 5.46 (85) 4.43 (69) 0.803 (0.580–1.112) 1.052 (0.760–1.455)
Electrolyte Abnormalities
Low magnesium with replacement 4.36 (68) 2.12 (33) 0.474 (0.311–0.723) 0.565 (0.362–0.880)
High magnesium 4.43 (69) 3.4 (53) 0.760 (0.528–1.095) 0.822 (0.553–1.221)
Low potassium with replacement 14.12 (220) 7.51 (117) 0.494 (0.39–0.625) 0.510 (0.393–0.660)
High potassium 9.44 (147) 6.87 (107) 0.708 (0.546–0.918) 0.848 (0.643–1.118)
Low sodium 39.41 (614) 30.62 (477) 0.678 (0.585–0.787) 0.703 (0.602–0.821)
High sodium 7 (109) 6.03 (94) 0.854 (0.642–1.135) 0.965 (0.710–1.311)
Low calcium with replacement 1.16 (18) 0.77 (12) 0.664 (0.319–1.383) 1.125 (0.534–2.369)
Metabolic Acidosis
Lactic (pH and lactate) 0.71 (11) 0.26 (4) 0.362 (0.115–1.139) 0.397 (0.106–1.487)
Metabolic (pH and bicarbonate) 2.76 (43) 1.22 (19) 0.435 (0.252–0.75) 0.749 (0.399–1.403)
Hyperchloremic (pH and chloride) 3.47 (54) 1.22 (19) 0.344 (0.203–0.583) 0.477 (0.262–0.868)
  1. aExcluded patients receiving warfarin